|
Status |
Public on Oct 28, 2018 |
Title |
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
30456386 |
Submission date |
Jul 09, 2018 |
Last update date |
Mar 27, 2019 |
Contact name |
Dena Leshkowitz |
E-mail(s) |
dena.leshkowitz@weizmann.ac.il
|
Organization name |
Weizmann Institute of Science
|
Department |
Bioinformatics Unit, Life Sciences Core Facilities
|
Street address |
P.O.B. 26
|
City |
Rehovot |
ZIP/Postal code |
76100 |
Country |
Israel |
|
|
Platforms (2) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
Samples (35)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE116816 |
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state [human] |
GSE116817 |
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state [mouse] |
|
Relations |
BioProject |
PRJNA480288 |